Skip to content
Recall Observatory FDA recall evidence

Drug product

Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 125 mg per 50 mL (2.5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-461-01), packaged in 25 Multiple Dose Vials per tray (NDC 63323-461-57), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

D-0127-2023

November 22, 2022

Class II

Product summary

Firm
Fresenius Kabi USA, LLC
Event
Event 91198
Status
Terminated
Classification
Class II
Quantity
40,375 vials
Official record key
drug-enforcement:D-0127-2023

Official wording

Reason: Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Code information: Batch #: 6128061, exp 03/2024; 6128663, 6128664, exp 05/2024

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent